Senior Scientists

I've enjoyed and agree with Murray Saffran's excellent commentary in The Scientist ["Senior Scientists' Experience Can Offer A Valuable Resource To Today's Students," Sept. 30, 1996, page 11]. I'm the vice president of quality and compliance in a small biotechnology company, where most of my colleagues are in their 20s and 30s. Nearing my 60th birthday, I encounter several advantages to my seniority every day. There are, for example, frequent opportunities to mentor the growth and development o

Written byJack Cohen
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

I've enjoyed and agree with Murray Saffran's excellent commentary in The Scientist ["Senior Scientists' Experience Can Offer A Valuable Resource To Today's Students," Sept. 30, 1996, page 11]. I'm the vice president of quality and compliance in a small biotechnology company, where most of my colleagues are in their 20s and 30s. Nearing my 60th birthday, I encounter several advantages to my seniority every day. There are, for example, frequent opportunities to mentor the growth and development of others. In addition, I'm a great source of professional war stories, which enables me to teach both theory and practice with meaningful, real-life examples.

Because I've realized most of my career aspirations and am not burdened by the uncertainties and anxieties of many of my colleagues, I am both nonthreatening and nonthreatenable. While my physical resiliency may be a bit less than some of my coworkers', I've learned to plan and prioritize ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies